Alsevalimab, CAS [[2254029-91-7]]

Produktübersicht

• Artikelname: Alsevalimab, CAS [[2254029-91-7]]
• Artikelnummer: TGM-T78287
• Hersteller Artikelnummer: T78287
• Alternativnummer: TGM-T78287-1MG, TGM-T78287-5MG, TGM-T78287-10MG, TGM-T78287-25MG, TGM-T78287-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: FPA-150 , FPA150 , Anti-B7-H4 antibody

Produktbeschreibung

Alsevalimab (FPA-150) is a humanized monoclonal antibody that targets B7-H4. Alsevalimab specifically binds to B7-H4 on the surface of tumor and immune cells, blocking its inhibitory signals on T-cell activation, reversing the immunosuppressive state of the tumor microenvironment, and activating the proliferation and tumor-killing functions of effector T cells. Alsevalimab also mediates ADCC effects, synergistically enhancing antitumor immunity. Alsevalimab is suitable for use in studies of solid tumors.

Produkteigenschaften

• Reinheit: 98.92%
• CAS Nummer: [2254029-91-7]
• Target-Kategorie: Others

Bilder

T78287